middle.news

OncoSil Medical gains institutional backing for commercial launch

5:11pm on Monday 7th of September, 2026 AEST Healthcare
Read Story

OncoSil Medical gains institutional backing for commercial launch

5:11pm on Monday 7th of September, 2026 AEST
Key Points
  • $4.0 million placement priced at a 9.9% premium
  • Approximately $1.6 million raised through early option exercise
  • Capital earmarked for US and Australian commercial launches
  • Three largest institutional investors backing the raise
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Oncosil Medical (ASX:OSL)
OPEN ARTICLE